Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Tocilizumab: Administration of 8mg/kg body weight (BW) Tocilizumab i.v. immediately afterrandomisation (total dose should not exceed 800mg) (single dose will be administered after randomisation) AND\u00e2?\u00a2 Conventional treatment (until discharge from the ICU)Control Intervention1: Normal Saline: Normal Saline will be used as placebo.Placebo i.v. immediately after randomisations (single dose) AND\u00e2?\u00a2 Conventional treatment (until discharge from the ICU)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Tocilizumab: Administration of 8mg/kg body weight (BW) Tocilizumab i.v. immediately afterrandomisation (total dose should not exceed 800mg) (single dose will be administered after randomisation) AND\u00e2?\u00a2 Conventional treatment (until discharge from the ICU)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Normal Saline: Normal Saline will be used as placebo.Placebo i.v. immediately after randomisations (single dose) AND\u00e2?\u00a2 Conventional treatment (until discharge from the ICU)", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1299, "treatment_name": "Tocilizumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

Nov. 13, 2021, 5:33 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

Jan. 15, 2021, 12:45 a.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Tocilizumab: Administration of 8mg/kg body weight (BW) Tocilizumab i.v. immediately afterrandomisation (total dose should not exceed 800mg) (single dose will be administered after randomisation) AND\u00e2?\u00a2 Conventional treatment (until discharge from the ICU)Control Intervention1: Normal Saline: Normal Saline will be used as placebo.Placebo i.v. immediately after randomisations (single dose) AND\u00e2?\u00a2 Conventional treatment (until discharge from the ICU)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Tocilizumab: Administration of 8mg/kg body weight (BW) Tocilizumab i.v. immediately afterrandomisation (total dose should not exceed 800mg) (single dose will be administered after randomisation) AND\u00e2?\u00a2 Conventional treatment (until discharge from the ICU)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Normal Saline: Normal Saline will be used as placebo.Placebo i.v. immediately after randomisations (single dose) AND\u00e2?\u00a2 Conventional treatment (until discharge from the ICU)", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]